A randomised, double-blind, placebo-controlled, multi-centre, dose-range, proof-of-concept, 24-week treatment study of lanifibranor in adult subjects with non-alcoholic steatohepatitis: Design of the NATIVE study
Title:
A randomised, double-blind, placebo-controlled, multi-centre, dose-range, proof-of-concept, 24-week treatment study of lanifibranor in adult subjects with non-alcoholic steatohepatitis: Design of the NATIVE study
Author:
Sven M., Francque Pierre, Bedossa Manal F., Abdelmalek Quentin M., Anstee Elisabetta, Bugianesi Vlad, Ratziu Philippe, Huot-Marchand Bruno, Scherrer Jean-Louis, Junien Pierre, Broqua Jean-Louis, Abitbol